Bazedoxifene: Kedu ihe ọ bụ maka na otu esi ewere ya

Ndinaya

• Ahịa
• Esi ewere
• Omume puru omume
• Onye ekwesighi

Bazedoxifene bụ ọgwụ eji agwọ ọrịa mgbe emechara mmekọrịta nwoke na nwanyị, ọkachasị okpomọkụ a na-eche na ihu, olu na obi. Ọgwụ a na-arụ ọrụ site n'inyere aka weghachite ogo nke estrogens na ahụ, mgbe ọgwụgwọ na progesterone adịghị ezu.

Na mgbakwunye, enwere ike iji Bazedoxifene gwọọ postmenopausal osteoporosis, na-ebelata ohere nke mgbaji ọkpụkpụ, ọkachasị na spain. A ka na-amụ ya dị ka ụzọ iji gbochie uto etuto dị n'ime ara, ma nwee ike inye aka n'ịgwọ ọrịa kansa.

Ahịa

Anvisa akwadoghị Bazedoxifene na Brazil, enwere ike ịchọta ya na Europe ma ọ bụ United States n'okpuru aha aha Osakidetza, Duavee, Conbriza ma ọ bụ Duavive.

Esi ewere

Ekwesịrị iji Bazedoxifene naanị mgbe emechara ụmụ nwanyị nwere akpa nwa, ma ọ dịkarịa ala ọnwa 12 kemgbe oge ịhụ nsọ ikpeazụ. Ngwá ọgwụ ahụ nwere ike ịdị iche na nke ọ bụla, ya mere, dọkịta kwesịrị igosi ya. Otú ọ dị, ọgwụ a tụrụ aro n'ọtụtụ ọnọdụ bụ:

• 1 mbadamba kwa ụbọchị ya na 20 mg nke Bazedoxifene.

N'ihe banyere ichefu, ị kwesịrị ị doseụ ọgwụ echefuru echefu ozugbo i chetara, ma ọ bụ were nke ọzọ ma ọ bụrụ na ọ dị nso na oge ọzọ, na-ezere ị tabletsụ mbadamba abụọ na-erughị awa isii.

Omume puru omume

Fọdụ n'ime mmetụta ndị kachasị emetụta iji ọgwụ a gụnyere candidiasis ugboro ugboro, mgbu afọ, afọ ntachi, afọ ọsịsa, ọgbụgbọ, mọzụlụ muscle na triglycerides na-arịwanye elu na ule ọbara.

Onye ekwesighi

Akwụghị Bazedoxifene maka ụmụ nwanyị nwere:

• Hipersensibility na usoro nke usoro a;
• Ọnụnọ, enyo ma ọ bụ akụkọ ihe mere eme nke ara, endometrial ma ọ bụ ndị ọzọ na-adabere na estrogen;
• Ọbara akụkụ ọbara na-amaghị nke ọma;
• Hyperplasia nke akpanwa na-agwọghị;
• Akụkọ banyere thrombosis;
• Ọrịa ọbara;
• Ọrịa imeju;
• Uzochukwu

Na mgbakwunye, ekwesighi iji ụmụ nwanyị na -abatabeghị nsọ, ọkachasị ma enwere nsogbu ime.